Pathology of immune-mediated tissue lesions following treatment with immune checkpoint inhibitors

Immune check point inhibitor (CPI) therapy has revolutionized treatment paradigms for several cancers, but at the cost of triggering a diverse spectrum of immune-mediated injury to non-cancer tissues. The complex biology of these toxicities remains incompletely understood, partly because tissue acqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibraheim, Hajir, Perucha, Esperanza, Powell, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900915/
https://www.ncbi.nlm.nih.gov/pubmed/31816081
http://dx.doi.org/10.1093/rheumatology/kez465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900915/
https://www.ncbi.nlm.nih.gov/pubmed/31816081
http://dx.doi.org/10.1093/rheumatology/kez465

Ejemplares similares